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Background. Excretion by the kidney of a variety of organic
anionic drugs and metabolites is mediated by a family of mul-
tispecific organic anion transporters (OAT genes) that are part
of the SLC22 family of solute carriers. Different OATs local-
ize to the apical (OAT2, OAT4, and RST/URAT) or basolat-
eral (OAT1/NKT and OAT3) membranes of the renal proximal
tubule; the net transport of organic anions from blood to urine
is believed to require both apical and basolateral OATs. These
genes are also thought to mediate transport of organic anionic
drugs and metabolites (e.g., urate) across choroid plexus, retina,
placenta, and possibly olfactory mucosa. The extent of func-
tional redundancy among OATs remains uncertain, but closely
related OAT genes are tightly linked in the genome. Hence,
a better understanding of human variation in organic anionic
drug excretion may be obtained by studying OAT genes in com-
bination rather than individually.
Methods. We have analyzed single nucleotide polymorphisms
(SNPs) in OAT1 (NKT), OAT2, OAT3, OAT4, and URAT1
(human homologue of RST) in an ethnically diverse sample
of 96 individuals (192 haploid genomes). Ka/Ks analysis was
also performed as well as haplotype reconstruction using the
software program Arelquin.
Results. The data indicate that (1) nonsynonymous SNPs in
OAT1 and OAT3 may not be frequent so it will be important
to consider promoter region SNPs that regulate gene expres-
sion; (2) certain ethnic groups may have a high prevalence of
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nonsynonymous SNPs in particular OATs (e.g., OAT4 in Sub-
Saharan Africans); (3) there are individuals who have nonsyn-
onymous SNPs in apical and basolateral OATs; (4) nonsynony-
mous OAT4 SNPs may be more frequent, raising the possibility
of altered maternofetal transport of drugs and metabolites; and
(5) combinations of synonymous SNPs in OAT1 and OAT3 also
occur in certain individuals. In addition, Ka/Ks analysis of hu-
man, chimp and rodent genes suggests that OAT4 is under ac-
celerated selection pressure, perhaps reflecting specific human
environmental exposures during evolution. In contrast, Ka/Ks
analysis for URAT1 suggests decelerated selection pressure.
Haplotype reconstruction also supports this view.
Conclusion. Together, these data suggest that, in order to
understand the effect of SNPs in genes of the SLC22 family
on drug handling as well as excretion of metabolites like uric
acid, it is important to consider the entire set of organic anion
transporters. It will be particularly interesting to determine if
individuals with nonsynonymous apical and basolateral SNPs
have altered handling (and toxicity) of organic anionic drugs
and metabolites. Certain OAT family members appear to be
under greater evolutionary selection pressure.
Many charged, soluble molecules are eliminated
through the kidney by transporters that are members
of the SLC22 family of solute carriers. This family
of transporters includes the organic anion transporters
(OATs), organic cation transporters (OCTs), carnitine
transporters (OCTNs), and a number of related genes
(USTs, Flipts, and RST/URAT1) in mammals [1]. The
gene family also extends to invertebrates, including flies
and nematodes. Many of these genes exist in pairs in the
human genome (e.g., OAT1/OAT3, OCT1/OCT2, and
OCTN1/OCTN2) [2]. Soluble anionic drugs tend to be
eliminated by the OATs, the prototype of which, OAT1,
was first identified as NKT in mice [3] and subsequently
shown to transport a variety of organic anions [4]. There
are now at least six OAT family members (OAT1-6).
Many are expressed in the proximal tubule, the site in
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the kidney where most soluble charged molecules are ex-
creted [5]. The list of drugs presumed to be transported
is long and includes many of the most commonly pre-
scribed medications such as penicillins, cephalosporins,
nonsteroidal anti-inflammatory drugs (NSAIDs), loop
and thiazide diuretics, statins, and antivirals. A number of
metabolites, including uric acid and folate, are also trans-
ported by the OATs and related genes like RST/URAT1.
The pathway is also important in the damage due to tox-
ins such as Ochratoxin A [6, 7]. OAT1 and OAT3 appear
to function as the major basolateral organic anion trans-
porters, acting on the blood side in the uptake of these
organic anionic drugs and metabolites into the proximal
tubule cell. Secretion into the urine (as well as uptake
from the filtrate) is thought to be mediated via the apical
transporters OAT4, RST/URAT1, and possibly OAT2.
Thus, this set of genes (OAT1 and OAT3 on the basolat-
eral side, and OAT4, RST/URAT1, and possibly OAT2
on the apical side) are responsible for the movement of
the aforementioned drugs, toxins, and metabolites from
the blood to the urine.
Mutations in coding regions of this set of genes are
likely to contribute to variation in renal drug clearance
[8]. Loss of the OAT3 gene in mice results in abnormal
renal and choroid plexus transport of certain organic an-
ions [9]. Nevertheless, the transport of some organic an-
ions was only partly affected, probably due to the expres-
sion of other family members. Mutations in OATs are
also known to affect transport function as determined
by in vitro transport assays such as microinjection into
Xenopus oocytes and transfection into COS-7 cells [7]. In
humans, mutation of URAT1 (the ortholog of the gene
first identified in mouse as RST), a urate transporter,
is known to result in hypouricemia [10]. Human single
nucleotide polymorphisms (SNPs) in OCT genes have
also been shown to be functionally defective by in vitro
transport assays. Since OAT1-4 and RST/URAT1 are to-
gether thought to regulate the movement of organic an-
ionic drugs and toxins from blood to urine, it is plausible
that one or more SNPs in the coding regions alter the
excretion of drugs and toxins by the kidney. Variation in
transport function may be under selection pressure in dif-
ferent environments and phenotypic variation is known
to show ethnogeographic differences. Thus, OAT family
polymorphisms should be studied in several populations.
Furthermore, the physiologic arguments outlined
above suggest that SNPs in the entire set of genes (OAT1-
4 and RST/URAT1) need to be considered, rather than
a single particular member in this set of genes, to ar-
rive at a more coherent picture of net excretion of drugs
and metabolites [11]. Presented here are the polymor-
phisms and gene haplotypes in the coding regions of this
set of genes that were identified from a subset of the
Human Gene Diversity Collection obtained from Coriell
Institute (NIGMS). The data support the view that it
is important to evaluate combinations of OAT1-4 and
RST/URAT1 polymorphisms in particular ethnic groups
when attempting to understand human variation in drug
excretion. The data also suggest that particular OATs may
have been under substantial selection pressure during hu-
man evolution.
METHODS
Subjects
Genomic samples were obtained from a Coriell
Institute diversity panel consisting of 96 individuals
representing the major ethnogeographic divisions.
Specifically, the panel was randomly selected from ma-
jor ethnic groups and included ten Chinese, nine Indo-
Pakistanis, ten Japanese, ten Southeast Asians, ten South
Americans (Andeans), nine Sub-Saharan Africans, ten
Ashkenazi Jews, seven North Africans, seven Pacific Is-
landers, five Southwest Americans/Mexican Indians, and
nine Northern Europeans. Individuals from the Coriell
panel are healthy; specific phenotypic information is not
available (Table 1) (http://locus.umdnj.edu/nigms/).
Molecular genetics and haplotype determination
DNA samples were obtained from the Coriell Institute.
Public human genome sequences were obtained from the
University of California Santa Cruz (UCSC) Genome
Browser (http://genome.ucsc.edu/). Polymerase chain re-
action (PCR) primers were designed using primers [12]
to span each exon of human OAT1, OAT2, OAT3,
OAT4, and URAT1. Target sequences were amplified by
PCR from 16 ng of genomic DNA in a final volume of
20 lL. Products were treated with exonuclease I and
shrimp alkaline phosphatase to remove primers and
deoxynucleotide triphosphates (dNTPs) prior to cycle
sequencing with BigDye terminators (Applied Biosys-
tems). The sequence was determined on an ABI
3100 automated sequencer and analyzed using the
Phred/Phrap/Consed suite of software to provide base
quality scores [13–15]. Polymorphisms and heterozygos-
ity were detected using Polyphred [16, 17] and were
manually confirmed. A subset of these data was cross-
validated manually through use of base calls from Ap-
plied Biosystems software, and visual inspection of trace
files was performed to identify heterozygotes. Haplotypes
were reconstructed using Phase 2.1.1, a software package
that uses Bayesian methods to assign haplotypes from
genomic data [18, 19]. Haplotype networks were con-
structed using Arlequin, a population genetics software
program which computes a matrix of distances between
pairs of haplotypes (http://lgb.unige.ch/arlequin/).
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Neutrality tests
To test whether or not these five genes have altered se-
lection in the human lineage, we performed the standard
neutrality tests, McDonald-Kreitman test, and Ka/Ks
test. Neutrality tests (Fu and Li D∗, F∗, Fu Fs, and Tajima
D) were carried out by DnaSP version 3.99. Mouse and
rat coding sequences for each gene were extracted from
the NCBI public database. Chimp coding sequences were
obtained by using human coding sequences against the
UCSC chimp sequence database with BLAT and checked
manually. The Ka (the number of nonsynonymous substi-
tutions per nonsynonymous site), and Ks (the number of
synonymous substitutions per synonymous site) for pair
of sequences were estimated by the methods described by
Nei and Gojobori [20] (1986) and performed by DnaSP
version 3.99. Ka and Ks should be close under neutral
selection so that the ratio of Ka/Ks is close to 1. Under
purifying selection the ratio will be less than 1; accelerated
positive selection will result in Ka/Ks more than 1. Alter-
natively, we also can ask whether there is a different ratio
in the human lineage compared with the ratio in other lin-
eages. Neutrality tests are based on the assumption that
all polymorphisms arise from neutral selection. There are
a variety of tests that can be employed to check whether
the distribution of polymorphisms on an interesting gene
or genome fragment is in line with the neutral assump-
tion. Tajima D test calculates pair-wise sequence diver-
sity to ask whether the value is consistent with neutrality.
Fu test is to use singleton (tip) and internal mutations
(branches) to estimate number and length of tip versus
internal branches to test for consistencies with neutrality.
The fixed differences between human and chimp were de-
rived by sequence alignment using ClustalW. Since chimp
URAT1 exon 1-3 sequences are not available in the pub-
lic database, partial comparison was done among species
without exon 1-3.
RESULTS
SNPs in basolateral transporters: OAT1 and OAT3
There are five SNPs are located on coding regions of
OAT1 (Table 1, first column). Two of these SNPs (T20C
and G149A) are nonsynonymous, resulting in amino acid
substitutions Leu7Pro and Arg50His, respectively (Table
1, second column). With respect to the T20C SNP, there is
only one gene with the minor allele (C) in the Southeast
Asian gene pool (total number of genes 20), resulting in a
major allele (T) frequency of 0.95 in the Southeast Asian
population (as listed in Table 1). Similarly, with respect to
G149A, there is only one gene with the minor allele (A)
in the Sub-Saharan African gene pool (total number of
genes 18), resulting in a major allele (G) frequency of 0.94
in the Sub-Saharan African population (Table 1). Geno-
types for individuals with at least one nonsynonymous
SNP are listed in Table 2. The individual of Southeast
Asian origin (identification number or ID #17081) with
the T20C SNP is heterozygous at this locus; the individ-
ual of Sub-Saharan African origin (ID #17342) with the
G149A SNP is also heterozygous.
The remaining three OAT1 SNPs are synonymous
and are found in several ethnic groups (Indo-Pakistani,
Japanese, Sub-Saharan African, Ashkenazi Jewish, North
Saharan African, and Northern European). Major allele
frequencies range from 0.83 to 0.95 in these ethnic groups
(Table 1). Ninety-six percent of OAT1 genes in this popu-
lation had TGGAC at nucleic acid positions 20, 149, 252,
351, and 1233, respectively (Fig. 1A). Reconstruction of
haplotype networks using the population genetics pro-
gram Arlequin indicates that the major haplotype (hap-
lotype 1) is the same as the ancestral chimp haplotype.
Five of the remaining six haplotypes appear to have been
derived from this ancestral haplotype (Fig. 1A).
There is one nonsynonymous coding region OAT3 SNP
(A523G, resulting in amino acid substitution Ile175Val)
in the Japanese gene pool, major allele frequency 0.95
(Table 1). The individual with this SNP (ID #17057) is het-
erozygous at this locus (Table 2). The remaining OAT3
SNPs (G153A and T723C) are synonymous, relatively
common, and are found in most ethnic groups (Table 1).
Eighty-six percent of OAT3 genes segregate into two
common haplotypes: GAT (63% of genes) and GAA
(23% of genes) at positions 153, 523, and 723, respec-
tively. Three of six haplotypes appear to have been de-
rived from the major ancestral/chimp (GAT) haplotype
(Fig. 1B.)
Several individuals also have SNPs on both OAT1 and
OAT3; two of these individuals carry a nonsynonymous
OAT1 SNP. An individual of Sub-Saharan African origin
(Table 2) (ID #17342), carries a nonsynonymous OAT1
SNP (G149A and G/A heterozygous) as well as a syn-
onymous OAT3 SNP (G153A and A/A homozygous).
Another subject of Southeast Asian origin (Table 2) (ID
#17081) has a nonsynonymous OAT1 SNP (T20C and
T/C heterozygous) as well as a synonymous OAT3 SNP
(T723A and T/A heterozygous).
SNPs in apical transporters: OAT4, URAT1, and OAT2
Coding regions for OAT4 and URAT1 have much
more nucleotide variation in comparison to OAT1 and
OAT3. Eight of the 11 SNPs on OAT4 are nonsynony-
mous; major allele frequencies range from 0.86 to 0.95
in ethnic groups with these SNPs (Table 1). One per-
son of Sub-Saharan African (Table 2) (ID #17345) ori-
gin has two of these nonsynonymous OAT4 SNPs (G37A
and G463A, heterozygous at both loci). Major allele fre-
quencies for synonymous OAT4 SNPs range from 0.80
to 0.95 in ethnic groups with these SNPs. Based on
comparison with the chimp sequence, the major OAT4
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Fig. 1. Haplotypes were inferred using PHASE and are shown in tabular format. (A) OAT1 haplotypes. (B) OAT3 haplotypes. Each circle represents
haplotypes for OAT1 and OAT3. Haplotype networks were constructed using Arlequin. Haplotypes that appear to be directly related (or have
originated from one another) are connected by solid lines. Alternate relationships are shown by dashed lines. Major haplotypes for OAT1 and
OAT2 are the same as the ancestral/chimp haplotypes (in bold).
haplotype (Fig. 2A, haplotype 1) is not the same as the
ancestral/chimp OAT4 haplotype, (Fig. 2A, haplotype 2).
In this case, the difference between the haplotypes is
the result of a G1015A polymorphism; the minor allele
(A) is the ancestral/chimp allele and exists only in Sub
Saharan Africans (14% minor allele frequency). There-
fore, the major human OAT4 haplotype (haplotype 1)
appears to be derived from the ancestral/chimp haplo-
type (haplotype 2); seven of the remaining eight hap-
lotypes appear to have been derived from haplotype 1
(Fig. 2A).
All of the six SNPs on URAT1 are synonymous
(Table 1). Four of these SNPs (C246T, C258T, C426T,
and T1309C) are found in most of the ethnic groups stud-
ied, major allele frequencies ranging from 0.17 to 0.94.
URAT1 haplotypes are shown in Figure 2B. Only five
haplotypes appear to have been derived from the ma-
jor ancestral/chimp haplotype (haplotype 1). Similar to
the OAT1-3 pair, SNPs on both OAT4 and URAT1 are
common in this population; several of these combinations
include nonsynonymous OAT4 SNPs (Table 2).
Three out of four OAT2 SNPs are nonsynonymous;
major allele frequencies for C329T, G571A, and G1520A
are 0.94, 0.94, and 0.95 in ethnic groups with these SNPs
(Table 1). The three individuals (each with one of these
nonsynonymous SNPs) are heterozygous at these loci
and are of Sub-Saharan African (C329T) (ID #17342),
Indo-Pakistani (G571A) (ID #17029), and Japanese
(G1520A) (ID #17060) origin (Table 2). The synonymous
OAT2 SNP (C1269T) is commonly found in all ethnic
groups (major allele frequency ranging from 0.22 to 0.78
(Table 1). The majority of OAT2 genes are one of two
haplotypes: CGCG (haplotype 1) or CGTG (haplotype
3) at positions 329, 571, 1269, and 1520, respectively
(Fig. 2C). Three haplotypes appear to have been derived
from the major ancestral/chimp haplotype (haplotype 1);
the remaining two haplotypes derived from haplotype 3
(Fig. 2C).
SNPs in basolateral and apical transporters
Because basolateral and apical transporters act to-
gether to clear organic anions from the kidney into the
blood (or vice versa), it may be important to charac-
terize the prevalence of SNPs on both basolateral and
apical transporter genes. One individual of Sub-Saharan
African origin (Table 2) (ID #17342) has a nonsynony-
mous change in a basolateral transporter (OAT1 and
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Fig. 2. Haplotypes were inferred using PHASE and are shown in tabular format. (A) OAT4 haplotypes. (B) URAT1 haplotypes. (C) OAT2
haplotypes. Each circle represents haplotypes for OAT4, URAT1, and OAT2. Haplotype networks were reconstructed using Arlequin. Haplotypes
that appear to be directly related (or have originated from one another) are connected by solid lines. Alternate relationships are shown by dashed lines
(not shown for URAT1 because of numerous alternate relationships). Major haplotypes for URAT1 and OAT4 are the same as the ancestral/chimp
haplotype (in bold). Note that the major haplotype for OAT4 (haplotype 1) is not the same as the chimp haplotype (haplotype 2). All remaining
human haplotypes appear to have originated from haplotype 1, suggesting selection away from the ancestral/chimp haplotype.
G149A), as well as a nonsynonymous change in an apical
transporter (OAT2 and C329T). Other individuals with
nonsynonymous changes (on basolateral or apical trans-
porters) have synonymous changes on the opposite set of
transporters.
Neutrality tests to identify possible selection pressure in
primates
At least one of the neutrality tests suggested significant
departure from neutrality (Table 3), indicating purifying
selective pressure on coding sequences. The Ka/Ks ratio
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Table 3. Neutrality tests
Gene Fu and Li Da Fu and Li Fa Fu Fs Tajima D
OAT1 0.983 0.439 −5.8b −0.833
OAT2 −2.974a −2.532a −0.963 −0.448
OAT3 0.776 0.839 −0.987 0.572
OAT4 −2.834a −3.052a −15.925c −2.055a
URAT1 1.067 1.255 −10.536c 1.03
aP < 0.05; bP < 0.01; cP < 0.001.
Table 4. Ka/Ks, pair-wise coding sequence comparisons
Gene Comparison Ka/Ks
OAT1 Human vs. human variant 0.239
Human vs. chimp 0.102
Mouse vs. rat 0.159
OAT2 Human vs. human variant 1.182
Human vs. chimp 0.189
Mouse vs. rat 0.237
OAT3 Human vs. human variant 0.160
Human vs. chimp 0.333
Mouse vs. rat 0.294
OAT4 Human vs. human variant 0.903
Human vs. chimp 0.225
URAT1 Human vs. human variant 0.000
Human vs. chimp 0.109
Chimp vs. mouse 0.302
was less than 1 for the majority of sequences compared,
confirming purifying selection for those genes (Table 4).
The comparison between Ka/Ks ratio in the human lin-
eage and that in other lineages should shed light on gene
evolution after divergence between human and chimp. In
the case of OAT4, which does not have an orthologue in
mouse and rat and probably appeared recently in human
and primates, the eight nonsynonymous and three syn-
onymous substitutions deviated significantly from neu-
trality in all tests (Table 3). In addition, the Ka/Ks ra-
tio in the human lineage is higher than between human
and chimp (0.903 vs. 0.225). This suggests that OAT4 may
have accelerated selective pressure in the human lineage,
presumably to better adapt to environmental alterations.
The same may apply to OAT2. In contrast, URAT1 has
an orthologue in mouse but not in rat and no synonymous
substitutions were observed. The Ka/Ks ratio is zero in
human lineage suggesting decelerated selection pressure.
It is interesting to note that OAT4 and URAT1 have high
similarity of protein sequences and possibly arise from the
same ancestral gene.
DISCUSSION
Solute carriers, OATs1-4 and URAT1 are highly con-
served across several species. Structural analysis sug-
gests that these proteins have 12 membrane-spanning
segments. In this study, we re-sequenced the coding re-
gions of these genes from an ethnically diverse, healthy
population. Twenty-nine SNPs were found, 13 of which
were located in the first exon of these genes. In addition,
14 of these SNPs are nonsynonymous, and eight of these
nonsynonymous SNPs are located on OAT4. In keeping
with an essential function for these solute carriers, allele
frequencies of these nonsynonymous SNPs are low. How-
ever, there is variation between ethnic groups. For ex-
ample, Sub-Saharan Africans appear to have a relatively
high frequency of nonsynonymous SNPs. Five of the 14
nonsynonymous SNPs in this study population are found
in Sub-Saharan Africans, with minor allele frequencies
ranging from 0.06 to as high as 0.11. Finally, several indi-
viduals with more than one SNP on basolateral and apical
transporters are also observed.
The genetic diversity among individuals of Sub-
Saharan descent is consistent with the hypothesis that the
human species evolved from the African subcontinent.
However, this observation also suggests that there may
be clinically significant differences between ethnic groups
with the risk of developing toxic and adverse drug reac-
tions to many commonly prescribed pharmaceutic agents.
Individuals with more than one nonsynonymous change
may be particularly vulnerable. For example, methotrex-
ate (an antineoplastic drug) and zidovudine (an antiviral
drug) are transported by OAT1 and OAT3 on the baso-
lateral membrane of the kidney proximal tubule cell and
by OAT4 on the apical membrane. Therefore, individu-
als of Sub-Saharan descent may be more susceptible to
the toxic side effects of these drugs [6]. Because OAT4
is also highly expressed in the placenta, a gain/or loss of
transporter function may place a fetus at a higher risk of
in utero toxicity if exposed to certain exogenous (e.g., an-
tiviral drugs) or endogenous molecules [21]. This body of
research is still very limited and this data simply suggests
potential at-risk populations.
These carriers transport many commonly prescribed
drugs (as well as other endogenous charged molecules);
variation in the function of these genes is likely to con-
tribute to the underexcretion (or overexcretion) and sub-
sequent increase (or decrease) of drugs and therefore
affect efficacy and/or toxicity. As an example, a single
SNP on exon 4 of the URAT1 gene (G744T) has been
shown to result in hypouricemia because a stop codon is
substituted for an amino acid (trytophan), resulting in a
truncated protein [10]. Synonymous changes these trans-
porter genes (especially URAT1) appear to be common;
synonymous SNPs may result in differences in DNA tran-
scription and/or message stability and the significance of
these changes is being further explored in both in vitro
and clinical studies in our laboratory. Although not dis-
cussed in this paper, the expression of these transporters
is also likely to be affected by polymorphisms in gene
promoter regions, which are also currently being charac-
terized by our laboratory.
Redundancy of function appears to be very important
in basolateral OATs (OAT1 and OAT3) and is supported
by in vivo genetic data [9]; this may be true for the apical
OATs as well. Because the net transport of organic anions
is likely to be a function of basolateral as well as apical
Xu and Bhatnagar et al: Analyses of coding region polymorphisms in human OATs 1499
OATs, in evaluating the contribution of SNPs in this sub-
family of SLC22 transporters, an accurate picture may
only be obtained by considering SNPs in the entire set
of genes involved in basolateral and apical transport of
a specific organic anion. Although here we have limited
the analysis to OAT1-4 and URAT1, since the basolat-
eral transport step involves a “tertiary” mechanism em-
ploying gradients generated by the sodium dicarboxylate
transporter and the sodium potassium adenosine triphos-
phatase (ATPase), it may be important to consider poly-
morphisms in these genes as well. Transport through the
proximal tubule cell may involve other genes, possibly in-
cluding genes participating in vesicular sequestration of
organic anions. Furthermore, genes regulating dicarboxy-
late metabolism may also affect the rates of transport [7].
Thus, it may be important to evaluate SNPs in all these
genes as well to arrive at a full picture of polymorphisms
affecting drug elimination. For example, we have identi-
fied an individual (ID #17342) with nonsynonymous SNPs
in both apical and basolateral OATs; it will be interest-
ing to determine whether more extreme phenotypes with
respect to drug and metabolite excretion than those with
a SNP in either gene alone will be demonstrated from
ongoing in vitro and in vivo studies in our laboratory.
Finally, tests for neutrality, coding sequence compar-
isons (Ka/Ks), and haplotype reconstruction suggest that
OAT4 (and probably OAT2) are under considerable se-
lection pressure. The major haplotype for OAT4, for ex-
ample, is different from the ancestral/chimp haplotype;
all remaining haplotypes appear to have originated from
this major haplotype. With the notable exception of Sub-
Saharan Africans, other ethnicities did not retain the non-
synonymous allele, suggesting that accelerated selection
pressure might be operative. This could conceivably re-
flect specific environmental exposures during human evo-
lution. The data indicate the need for further analysis
by comparison of multiple primate coding sequences to
better understand selection pressures on the genes and
explore the functional significance of this result.
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